Every NR4A2 paper, in plain English

Directed differentiation of postnatal hippocampal neural stem cells generates nuclear receptor related‑1 protein‑ and tyrosine hydroxylase‑expressing cells.

Ding Y, Zhang Z, Ma J, Xia H, Wang Y, Liu Y, Ma Q, Sun T, Liu J

This study shows that neural stem cells from postnatal mouse brains can be directed to become dopamine-producing neurons in a lab dish. The researchers found that reducing serum levels in the culture medium significantly increases the production of these specific nerve cells.

• Mouse hippocampal stem cells differentiate into astrocytes in standard serum conditions.
• Low serum conditions markedly increase the number of neurons expressing dopamine markers.
• Nurr1 and tyrosine hydroxylase positive cells increase with longer differentiation time.
• Results suggest these cells could serve as a source for Parkinson's disease cell therapy.

Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells.

Grow DA, Simmons DV, Gomez JA, Wanat MJ, McCarrey JR, Paladini CA, Navara CS

Researchers successfully created functional dopamine-producing neurons from baboon stem cells that mimic human midbrain cells. This study establishes a large animal model to test the safety and efficacy of future stem cell therapies for Parkinson's disease.

• Baboon stem cells differentiate into dopamine neurons expressing key markers like NURR1 and TH.
• These neurons fire electrical signals and release catecholamines, proving functional maturity.
• The baboon model offers neuroanatomical similarities to humans for preclinical therapy testing.
• This work supports future safety trials of stem cell transplants in Parkinson's disease.

The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection.

Pinkham C, An S, Lundberg L, Bansal N, Benedict A, Narayanan A, Kehn-Hall K

This study shows that STAT3 helps protect cells during Rift Valley fever virus infection by controlling the location of a viral protein, which in turn affects cell survival. The findings suggest that STAT3's role in regulating gene expression, including the NR4A2 gene, may influence how cells respond to viral damage.

• STAT3 protects cells from virus-induced death
• STAT3 controls where a viral protein moves in the cell
• NR4A2 gene expression is reduced during infection
• STAT3 helps regulate viral protein localization
• This pathway may affect cell survival during infection

Active coping of prenatally stressed rats in the forced swimming test: involvement of the Nurr1 gene.

Montes P, Ruiz-Sánchez E, Calvillo M, Rojas P

Reducing Nurr1 levels in the hippocampus of non-stressed adult rats induces depressive-like behavior, while prenatal stress appears to protect against this effect by maintaining Nurr1 expression. This suggests that Nurr1 plays a critical role in how early life stress influences resilience or vulnerability to stress-related behaviors in adulthood.

• Lowering Nurr1 in adult rats causes depressive-like immobility in stress tests.
• Prenatal stress prevents this effect by maintaining normal Nurr1 levels.
• Nurr1 helps regulate brain responses to acute stress in adulthood.
• This is a rat study with no direct human clinical data.

Nuclear receptor expression atlas in BMDCs: Nr4a2 restricts immunogenicity of BMDCs and impedes EAE.

Saini A, Mahajan S, Gupta P

This study shows that the Nr4a2 protein helps regulate immune cells in mice, specifically reducing inflammation and protecting against an autoimmune disease model. The findings focus entirely on immune system modulation rather than brain development or dopamine neuron function relevant to NR4A2 syndrome.

• Nr4a2 suppresses activation of dendritic cells triggered by inflammatory signals.
• The protein promotes a tolerogenic phenotype in immune cells.
• Nr4a2 increases regulatory T cells and limits effector T cells in mice.
• Protection was observed in an experimental autoimmune encephalomyelitis model.
• Results suggest Nr4a2 as a potential target for immune-related pathologies.

Induction of specific neuron types by overexpression of single transcription factors.

Teratani-Ota Y, Yamamizu K, Piao Y, Sharova L, Amano M, Yu H, Schlessinger D, Ko MS, Sharov AA

This study demonstrates that overexpressing the NR4A2 transcription factor in embryonic stem cells directs them to become dopaminergic neurons. It confirms NR4A2's role as a specific genetic switch for this neuron type but relies entirely on cell culture models.

• NR4A2 induces dopaminergic markers when overexpressed in embryonic stem cells.
• The research uses in vitro cell cultures, not animal or human subjects.
• No clinical data or treatment outcomes for patients are reported.
• The study focuses on basic molecular mechanisms of neuron differentiation.

Effect of spontaneous term labour on the expression of the NR4A receptors nuclear receptor related 1 protein (Nurr1), neuron-derived clone 77 (Nur77) and neuron-derived orphan receptor 1 (NOR1) in human fetal membranes and myometrium.

Lappas M

This study shows that NR4A receptors increase in human uterine tissue during labor and when exposed to bacterial products, suggesting they help drive the inflammatory processes of birth. This finding does not provide information about NR4A2-related syndrome or potential treatments for it.

• NR4A receptor levels rise in fetal membranes and myometrium during spontaneous term labor.
• Bacterial products trigger increased expression of these receptors in uterine tissues.
• The study focuses on normal labor mechanisms, not NR4A2-related syndrome.
• No clinical data or treatment implications for NR4A2 children are presented.

Using iPSC-derived human DA neurons from opioid-dependent subjects to study dopamine dynamics.

Sheng Y, Filichia E, Shick E, Preston KL, Phillips KA, Cooperman L, Lin Z, Tesar P, Hoffer B, Luo Y

This study uses human stem-cell-derived dopamine neurons to show that genetic variations in the dopamine transporter and exposure to valproic acid alter gene expression related to addiction. It does not investigate NR4A2 mutations or provide evidence relevant to NR4A2-related syndrome.

• Study focuses on opioid addiction, not NR4A2-related syndrome.
• Uses iPSC-derived dopamine neurons from human subjects.
• Examines dopamine transporter genetics and valproic acid effects.
• No findings apply to NR4A2 variants or treatment.

Developmental gene expression in the mouse clarifies the organization of the claustrum and related endopiriform nuclei.

Watson C, Puelles L

This study maps the developmental origins of the mouse claustrum and endopiriform nuclei, showing that specific subpopulations express the Nr4a2 gene during embryonic formation. It details how these Nr4a2-positive cells migrate to form distinct brain structures but does not investigate human disease or clinical outcomes.

• Mouse claustrum primordium cells express Nr4a2 during early development.
• Dorsal endopiriform nucleus derives from Nr4a2-positive lateral pallial cells.
• Ventral endopiriform nucleus forms from Nr4a2-negative ventral pallial cells.
• Insular cortex cells migrate through the claustrum but are Nr4a2-negative.
• The study focuses on anatomical organization, not human pathology or treatment.

Efficient generation of dopaminergic-like neurons by overexpression of Nurr1 and Pitx3 in mouse induced Pluripotent Stem Cells.

Salemi S, Baktash P, Rajaei B, Noori M, Amini H, Shamsara M, Massumi M

Researchers successfully convert mouse stem cells into dopamine-producing neurons by adding two specific genes, Nurr1 and Pitx3. This technique creates functional nerve cells in a lab dish that release dopamine when stimulated.

• Mouse stem cells become dopamine neurons using Nurr1 and Pitx3 genes.
• Generated cells produce and secrete dopamine in response to stimuli.
• This method offers a potential source of cells for future Parkinson's therapies.

In situ hybridization analyses of claustrum-enriched genes in marmosets.

Watakabe A

This study maps where specific genes, including NR4A2 (Nurr1), are active in the brains of marmosets to understand brain structure. It confirms that Nurr1 is highly concentrated in the claustrum and certain cortical neurons, matching patterns seen in other primates. The research provides comparative anatomical data but does not address disease mechanisms or treatments for NR4A2-related syndromes.

• NR4A2 (Nurr1) shows high expression in the marmoset claustrum and specific cortical neurons.
• Gene expression patterns in marmosets closely match those previously described in macaques.
• The study compares gene locations across species to highlight conserved brain architecture features.
• No clinical data, patient outcomes, or therapeutic insights for NR4A2 syndromes are presented.

Identification of a Binding Site for Unsaturated Fatty Acids in the Orphan Nuclear Receptor Nurr1.

de Vera IM, Giri PK, Munoz-Tello P, Brust R, Fuhrmann J, Matta-Camacho E, Shang J, Campbell S, Wilson HD, Granados J, Gardner WJ, Creamer TP, Solt LA, Kojetin DJ

Unsaturated fatty acids, including DHA, bind directly to the Nurr1 protein and alter its activity in cellular environments. This study identifies the specific location where these fats attach to the receptor but does not test any treatments or outcomes in humans.

• DHA binds to the ligand-binding pocket of the Nurr1 protein.
• Fatty acid binding changes how Nurr1 interacts with other proteins.
• This is a structural biology study using biochemical assays and NMR.
• No human patients, clinical trials, or therapeutic interventions are involved.

Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.

Hattangady NG, Karashima S, Yuan L, Ponce-Balbuena D, Jalife J, Gomez-Sanchez CE, Auchus RJ, Rainey WE, Else T

Mutant KCNJ5 increases aldosterone production by activating both immediate and long-term pathways in adrenal cells, and the drug verapamil blocks these effects. This provides a potential treatment strategy for certain forms of adrenal overactivity.

• Mutant KCNJ5 boosts aldosterone production through multiple pathways
• Verapamil stops the abnormal hormone production
• The mutation affects both short-term and long-term hormone regulation
• Findings may help treat specific adrenal disorders

Erratum for the Research Article: "α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons" by M. Decressac, B. Kadkhodaei, B. Mattsson, A. Laguna, T. Perlmann, A. Björklund.

This paper is an erratum correcting a previous study on how alpha-synuclein affects dopamine neurons in Parkinson's disease models. It does not present new findings or data relevant to NR4A2-related syndromes.

• This is a correction notice, not original research.
• It addresses errors in a prior study on Parkinson's disease mechanisms.
• The content focuses on alpha-synuclein and GDNF signaling in mice.
• No new information about NR4A2 or human genetics is provided.

Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.

Zhang L, Cen L, Qu S, Wei L, Mo M, Feng J, Sun C, Xiao Y, Luo Q, Li S, Yang X, Xu P

Activating the Wnt/beta-catenin signaling pathway protects dopaminergic cells from toxin-induced damage by increasing Nurr1 levels. This protective effect relies on beta-catenin directly interacting with Nurr1 to enhance its expression.

• GSK3beta inhibitors protect PC12 cells from rotenone toxicity.
• Protection requires beta-catenin and increased Nurr1 expression.
• Beta-catenin physically interacts with Nurr1 to drive this effect.
• Study uses only cell lines, not animals or humans.

Efficient derivation of dopaminergic neurons from SOX1⁻ floor plate cells under defined culture conditions.

Li M, Zou Y, Lu Q, Tang N, Heng A, Islam I, Tong HJ, Dawe GS, Cao T

Researchers develop a method to create functional dopaminergic neurons from human stem cells without using sonic hedgehog signaling. These engineered neurons successfully improve motor symptoms when transplanted into a rat model of Parkinson's disease.

• The study uses human embryonic stem cells, not NR4A2 patient data or clinical trials.
• It focuses on general dopaminergic neuron derivation for Parkinson's disease research.
• Results are limited to preclinical animal models and in vitro cell culture.
• No direct link to NR4A2 syndrome mechanisms or treatments is established.

Methyl-Arginine Profile of Brain from Aged PINK1-KO+A53T-SNCA Mice Suggests Altered Mitochondrial Biogenesis.

Auburger G, Gispert S, Brehm N

This study analyzes brain tissue from mice with Parkinson's disease-related genetic mutations to identify changes in protein modifications linked to mitochondrial function. It finds that specific proteins interacting with NURR1 are dysregulated, suggesting a link between mitochondrial stress and dopaminergic neuron vulnerability.

• Researchers studied aged mice with combined PINK1 and SNCA mutations.
• Proteomic analysis focused on methyl-arginine modifications in brain tissue.
• Proteins interacting with NURR1 showed significant dysregulation.
• Mitochondrial biogenesis pathways appear stressed in these models.
• Findings highlight midbrain vulnerability through mitochondrial homeostasis disruption.

Regulation of differentiation flux by Notch signalling influences the number of dopaminergic neurons in the adult brain.

Trujillo-Paredes N, Valencia C, Guerrero-Flores G, Arzate DM, Baizabal JM, Guerra-Crespo M, Fuentes-Hernández A, Zea-Armenta I, Covarrubias L

Reduced Notch signaling causes dopaminergic neurons to differentiate too early, which ultimately decreases the total number of these neurons in the adult brain. This mechanism explains how genetic variations affecting cell development can lead to a lower density of dopamine-producing cells.

• Notch signaling controls when neural precursors expand versus when they become neurons.
• Premature differentiation reduces the pool of precursor cells available for future neuron production.
• Adult mice with reduced Notch activity show consistently fewer dopaminergic neurons in key brain regions.
• The study uses a mathematical model to confirm this feedback loop regulates neuron numbers.

A MED13-dependent skeletal muscle gene program controls systemic glucose homeostasis and hepatic metabolism.

Amoasii L, Holland W, Sanchez-Ortiz E, Baskin KK, Pearson M, Burgess SC, Nelson BR, Bassel-Duby R, Olson EN

This study identifies a molecular pathway in skeletal muscle that regulates whole-body glucose and liver fat metabolism through the interaction of MED13, NURR1, and MEF2. It demonstrates that suppressing this specific gene program in mice improves insulin sensitivity and prevents fatty liver disease.

• MED13 suppresses glucose uptake genes in muscle by inhibiting NURR1 and MEF2.
• Blocking MED13 in mouse muscle increases glycogen storage and lowers blood sugar.
• Reduced MED13 activity prevents fatty liver accumulation in mice on high-fat diets.
• The mechanism links skeletal muscle metabolism directly to hepatic lipid control.

DJ-1/PARK7, But Not Its L166P Mutant Linked to Autosomal Recessive Parkinsonism, Modulates the Transcriptional Activity of the Orphan Nuclear Receptor Nurr1 In Vitro and In Vivo.

Lu L, Zhao S, Gao G, Sun X, Zhao H, Yang H

The protein DJ-1 enhances the activity of Nurr1 (NR4A2) through a specific cellular signaling pathway, but a disease-linked mutant form of DJ-1 fails to do so. This interaction occurs in laboratory settings and animal models, suggesting a molecular link between DJ-1 function and NR4A2 regulation.

• DJ-1 boosts Nurr1 activity via the Raf/MEK/ERK signaling pathway.
• The L166P mutant of DJ-1 does not enhance Nurr1 activity.
• Reducing DJ-1 levels decreases Nurr1 transcriptional activity.
• Findings are based on in vitro and in vivo animal models.
• No human clinical data or treatment outcomes are reported.

Differential Neuronal Plasticity of Dental Pulp Stem Cells From Exfoliated Deciduous and Permanent Teeth Towards Dopaminergic Neurons.

Majumdar D, Kanafi M, Bhonde R, Gupta P, Datta I

Adult tooth stem cells differentiate into dopaminergic neurons more effectively than baby tooth stem cells when exposed to midbrain signaling cues. This difference stems from higher levels of Sonic Hedgehog receptors and lower basal dopamine production in the adult cells, allowing for greater functional maturation.

• Adult tooth stem cells yield significantly more functional dopaminergic neurons than baby tooth stem cells.
• Adult cells express higher levels of Sonic Hedgehog receptors, enhancing their differentiation potential.
• Baby tooth stem cells show lower receptor expression and reduced capacity for neuronal plasticity.
• Induced adult cells demonstrate superior dopamine release and calcium signaling capabilities.

Prostaglandins from Cytosolic Phospholipase A2α/Cyclooxygenase-1 Pathway and Mitogen-activated Protein Kinases Regulate Gene Expression in Candida albicans-infected Macrophages.

Yun B, Lee H, Jayaraja S, Suram S, Murphy RC, Leslie CC

This study investigates how macrophages respond to fungal infections, identifying that specific signaling pathways regulate the expression of the Nr4a2 gene within immune cells. The findings focus on molecular mechanisms in mouse macrophages and do not provide information about human NR4A2-related syndromes or potential treatments.

• The study uses mouse macrophages infected with Candida albicans, not human patients.
• Nr4a2 expression increases in immune cells during fungal infection via specific signaling pathways.
• Prostaglandins and MAPK kinases coordinate gene regulation in this immune response model.
• No clinical data, patient phenotypes, or therapeutic interventions for NR4A2 syndromes are presented.

Identification of upstream regulators for synovial expression signature genes in osteoarthritis.

Fei Q, Lin J, Meng H, Wang B, Yang Y, Wang Q, Su N, Li J, Li D

This study identifies NR4A2 as one of the top transcription factors regulating gene expression in the synovial tissue of osteoarthritis patients. The research suggests that NR4A2 could serve as a potential therapeutic target for treating osteoarthritis.

• NR4A2 is identified as a crucial upstream regulator in osteoarthritis synovial tissue.
• The study analyzes gene expression data from six osteoarthritis datasets.
• NR4A2 appears among the top ten transcription factors linked to disease genes.
• Findings propose NR4A2 as a potential new therapeutic target for osteoarthritis.

Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation.

Sundén H, Schäfer A, Scheepstra M, Leysen S, Malo M, Ma JN, Burstein ES, Ottmann C, Brunsveld L, Olsson R

Researchers developed a synthetic molecule that strongly activates the RXR-Nurr1 receptor complex in cell cultures. This work identifies a potential chemical tool for studying this pathway but does not involve human trials or direct treatment of NR4A2-related syndromes.

• The study focuses on RXR-Nurr1 dimer activation, not isolated NR4A2 function.
• Findings are limited to cell-based assays and X-ray crystallography structures.
• No animal models or human clinical data are presented in this paper.
• This is early-stage medicinal chemistry without immediate therapeutic application.

Directed Differentiation of Dopamine-Secreting Cells from Nurr1/GPX1 Expressing Murine Embryonic Stem Cells Cultured on Matrigel-Coated PCL Scaffolds.

Terraf P, Babaloo H, Kouhsari SM

Researchers successfully generated dopamine-secreting cells from mouse embryonic stem cells using a specialized scaffold and genetic modification. This preclinical study demonstrates a potential method for producing functional dopaminergic neurons for future cell replacement therapies in Parkinson's disease.

• The study uses mouse, not human, embryonic stem cells.
• Genetic modification adds Nurr1 and GPX-1 to the stem cells.
• Cells secrete dopamine when cultured on specific nanofibrous scaffolds.
• This is basic tissue engineering research with no human data.
• It does not address NR4A2 variants or current treatments for children.

High risk of adrenal toxicity of N1-desoxy quinoxaline 1,4-dioxide derivatives and the protection of oligomeric proanthocyanidins (OPC) in the inhibition of the expression of aldosterone synthetase in H295R cells.

Wang X, Yang C, Ihsan A, Luo X, Guo P, Cheng G, Dai M, Chen D, Liu Z, Yuan Z

N1-desoxy metabolites of certain quinoxaline antibiotics are highly toxic to adrenal cells and reduce aldosterone production by suppressing key genes and proteins involved in hormone synthesis. Natural antioxidants called OPC can protect adrenal cells by restoring the expression of these critical genes.

• N1-desoxy metabolites of quinoxaline drugs are toxic to adrenal cells
• These metabolites reduce aldosterone by lowering key enzyme genes
• Oligomeric proanthocyanidins (OPC) protect adrenal cells
• OPC restore gene expression and hormone production
• Findings may guide safer drug design and food safety rules

[Pathological mechanism of secondary-progressive multiples sclerosis and its animal model].

Oki S

This study identifies a specific immune cell type that drives the progressive neurodegeneration seen in secondary-progressive multiple sclerosis. It reveals that these cells release an enzyme that triggers inflammation, offering a potential new target for therapies aimed at slowing disease progression.

• NR4A2 is linked to early MS symptoms, not the progressive phase studied here.
• Eomes-expressing CD4+ T cells drive late-stage neurodegeneration in this model.
• Granzyme B from these cells activates receptors causing brain inflammation.
• Targeting Eomes or its enzyme may help treat progressive MS.

Parkinson's Disease, Diabetes and Cognitive Impairment.

Ashraghi MR, Pagano G, Polychronis S, Niccolini F, Politis M

This narrative review discusses shared biological mechanisms between Parkinson's disease, diabetes, and cognitive impairment, highlighting potential repurposing of anti-diabetic drugs. It mentions patents targeting Nurr1 (NR4A2) but does not provide specific clinical data or treatment outcomes for NR4A2-related syndromes.

• The paper reviews shared pathophysiology between Parkinson's, diabetes, and cognitive impairment.
• Anti-diabetic agents like GLP-1 agonists show promise in animal and human studies for Parkinson's.
• Recent patents target Nurr1, PINK1, and NrF2 proteins for novel Parkinson's treatments.
• The review does not report clinical results or genetic findings specific to NR4A2 mutations.

Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression.

Saito-Hakoda A, Uruno A, Yokoyama A, Shimizu K, Parvin R, Kudo M, Saito-Ito T, Sato I, Kogure N, Suzuki D, Shimada H, Yoshikawa T, Fujiwara I, Kagechika H, Iwasaki Y, Kure S, Ito S, Sugawara A

RXR agonists suppress tumor growth and ACTH secretion in pituitary corticotroph tumors by downregulating Nurr1 expression. This mechanism suggests potential therapeutic value for Cushing's disease but does not address NR4A2-related neurodevelopmental syndromes.

• RXR agonists induce apoptosis and inhibit proliferation in pituitary tumor cells.
• Treatment reduces ACTH secretion by suppressing Nurr1 transcription factor expression.
• The study focuses on Cushing's disease, not NR4A2-related developmental disorders.
• Findings are preclinical, using cell lines and mouse models only.

Orphan nuclear receptor NR4A2 inhibits hepatic stellate cell proliferation through MAPK pathway in liver fibrosis.

Chen P, Li J, Huo Y, Lu J, Wan L, Li B, Gan R, Guo C

NR4A2 levels are reduced in liver cells during fibrosis, and low NR4A2 leads to increased cell growth and scarring. Restoring NR4A2 activity may help slow or stop liver damage by regulating key cell pathways.

• NR4A2 is lower in fibrotic liver tissue
• Low NR4A2 increases scar-forming cell growth
• NR4A2 helps control liver scarring via MAPK pathway
• Boosting NR4A2 could be a treatment strategy

Hnrnph1 Is A Quantitative Trait Gene for Methamphetamine Sensitivity.

Yazdani N, Parker CC, Shen Y, Reed ER, Guido MA, Kole LA, Kirkpatrick SL, Lim JE, Sokoloff G, Cheng R, Johnson WE, Palmer AA, Bryant CD

This study identifies Hnrnph1 as a gene that regulates sensitivity to methamphetamine in mice by influencing the expression of Nr4a2, a transcription factor critical for dopaminergic neuron development. The research demonstrates that reducing Hnrnph1 levels lowers Nr4a2 expression and decreases behavioral responses to stimulants in animal models.

• Hnrnph1 regulates methamphetamine sensitivity in mice through dopaminergic pathways.
• Reduced Hnrnph1 leads to decreased Nr4a2 expression in the striatum.
• Nr4a2 is essential for midbrain dopaminergic neuron development.
• The study uses mouse models, not human participants or clinical data.

Selective early expression of the orphan nuclear receptor Nr4a2 identifies the claustrum homolog in the avian mesopallium: Impact on sauropsidian/mammalian pallium comparisons.

Puelles L, Ayad A, Alonso A, Sandoval JE, MartÍnez-de-la-Torre M, Medina L, Ferran JL

This study identifies a brain region in chickens that corresponds to the claustrum in mammals based on early Nr4a2 gene expression. It maps the developmental timing and location of these cells to compare avian and mammalian brain structures. The research focuses entirely on evolutionary neuroanatomy rather than human disease mechanisms or treatments.

• Nr4a2 marks an early-developing brain region in chickens comparable to the mammalian claustrum.
• The study compares spatial and chronological gene expression patterns across species.
• It proposes a homologous relationship between avian mesopallium and mammalian insula/claustrum.
• The research uses chicken and turtle models for evolutionary brain mapping.
• No human data, clinical outcomes, or therapeutic implications are presented.

Understanding gene expression in coronary artery disease through global profiling, network analysis and independent validation of key candidate genes.

Arvind P, Jayashree S, Jambunathan S, Nair J, Kakkar VV

This study investigates gene expression changes in blood samples from adults with coronary artery disease, identifying NR4A2 as one of several genes with altered activity. It does not provide information on the role of NR4A2 in neurodevelopment or its relevance to your child's specific syndrome.

• Researchers analyzed blood gene expression in adults with coronary artery disease versus healthy controls.
• NR4A2 was among the genes validated as having different expression levels in patients.
• The study focuses on cardiovascular inflammation and immune response pathways.
• No findings relate to brain development, dopamine systems, or pediatric neurology.

The Key Proteins of Dopaminergic Neurotransmission of Human Peripheral Blood Lymphocytes: Changed mRNA Level in Alcohol Dependence Syndrome.

Taraskina AE, Grunina MN, Zabotina AM, Nasyrova RF, Ivanov MV, Krupitsky EM, Schwartzman AL

People with alcohol dependence show higher levels of SNCA and DRD4 genes in blood cells, but no change in NR4A2, which is the gene linked to your child's condition. These gene changes may help track the condition but are not directly related to NR4A2-related syndrome.

• SNCA and DRD4 are elevated in alcohol dependence
• NR4A2 levels unchanged in this study
• Blood gene levels may serve as markers
• Findings not relevant to NR4A2-related syndrome
• No therapeutic implications for NR4A2

Zdhhc15b Regulates Differentiation of Diencephalic Dopaminergic Neurons in zebrafish.

Wang F, Chen X, Shi W, Yao L, Gao M, Yang Y, Hao A

This study shows that the gene Zdhhc15b is essential for the development of dopamine-producing neurons in zebrafish, as reducing its function leads to fewer mature neurons and behavioral deficits. The research identifies Nurr1 (NR4A2) as a key downstream target whose expression drops when Zdhhc15b is impaired, linking this protein to dopaminergic differentiation.

• Zdhhc15b knockdown reduces mature dopamine neurons and shrinks the zebrafish diencephalon.
• Reduced Zdhhc15b lowers expression of Nurr1, FoxA2, and Lmx1a transcription factors.
• Impaired Zdhhc15b causes poor learning behavior in zebrafish models.
• Zdhhc15b regulates neuronal fate decisions rather than cell survival or proliferation.

Coalition of Nuclear Receptors in the Nervous System.

Förthmann B, Aletta JM, Lee YW, Terranova C, Birkaya B, Stachowiak EK, Stachowiak MK, Claus P

This review describes how the nuclear form of the FGFR1 receptor interacts with other proteins, including Nurr1 (NR4A2), to regulate gene expression during neural development. It highlights specific molecular coalitions involved in neuronal stem cell differentiation and the formation of dopaminergic neurons.

• FGFR1 acts as a central signaling module directing post-mitotic neural cell development.
• The paper details FGFR1 interactions with Nurr1 during mesencephalic dopaminergic neuron development.
• It explores how nerve growth factor signaling modulates these nuclear receptor coalitions.
• The focus is on non-canonical tyrosine kinase signaling mechanisms in neurons.

Structure of distress call: implication for specificity and activation of dopaminergic system.

Mariappan S, Bogdanowicz W, Raghuram H, Marimuthu G, Rajan KE

Distress calls in fruit bats contain specific information about stress that triggers a dopamine-related brain response in both callers and listeners, suggesting the call structure directly activates the brain's stress and social communication pathways.

• Distress calls signal stress and attract other bats
• Natural calls activate dopamine brain circuits more than altered calls
• Brain changes occur in areas linked to emotion and social response
• Call structure is critical for triggering the correct neural response

Optogenetic Inhibitor of the Transcription Factor CREB.

Ali AM, Reis JM, Xia Y, Rashid AJ, Mercaldo V, Walters BJ, Brechun KE, Borisenko V, Josselyn SA, Karanicolas J, Woolley GA

Researchers develop a light-controlled tool to inhibit the transcription factor CREB, which successfully regulates NR4A2 expression in neurons. This method allows precise spatiotemporal control of gene activity using blue light.

• The tool opto-DN-CREB inhibits CREB function when exposed to blue light.
• It works by preventing CREB from binding to its target DNA sites.
• Blue light activation controls NR4A2 and c-Fos expression in neurons.
• This approach offers a general method for controlling native transcriptional events.

Intergenerational Effect of Early Life Exposure to Permethrin: Changes in Global DNA Methylation and in Nurr1 Gene Expression.

Bordoni L, Nasuti C, Mirto M, Caradonna F, Gabbianelli R

Early-life exposure to the pesticide permethrin causes lasting changes in DNA methylation and Nurr1 gene expression that pass from exposed parents to their untreated offspring. This intergenerational damage suggests that environmental toxins can alter genetic regulation in ways that affect future generations.

• Permethrin exposure in early life alters Nurr1 gene expression in rat offspring.
• Mothers and offspring show decreased global DNA methylation after exposure.
• One-third of progeny exhibit the same Nurr1 alterations as exposed parents.
• This is the first identified case of intergenerational pesticide-induced damage.

Development and function of the midbrain dopamine system: what we know and what we need to.

Bissonette GB, Roesch MR

This review summarizes current knowledge on how midbrain dopamine neurons develop and function, linking these processes to movement disorders like Parkinson's disease as well as conditions such as autism and schizophrenia. It highlights key molecular players involved in this development and identifies gaps in understanding that may guide future research into dopamine-related disorders.

• Midbrain dopamine neuron development is linked to Parkinson's, autism, and schizophrenia.
• Review covers major molecular and genetic factors in dopamine neuron ontogeny.
• Identifies knowledge gaps for future study on dopamine-related disorders.
• Aims to bridge developmental and behavioral neuroscience fields.